concept

PARP INHIBITORS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PARP INHIBITORS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

21Connections

0Hypotheses

2Analyses

19Outgoing

2Incoming

0Experiments

2Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	PARP INHIBITORS

Pathway Diagram

graph TD
    PARP_INHIBITORS[PARP INHIBITORS]
    PARP_INHIBITORS -->|treats| Homologous_Recombination_Defic[Homologous Recombination-Deficient Cancers]
    PARP_INHIBITORS -->|targets| PARP1[PARP1]
    PARP_INHIBITORS -->|underlies_sensitivity_to| Transcription_replication_conf[Transcription-replication conflicts]
    PARP_INHIBITORS -->|traps| PARP[PARP]
    PARP_INHIBITORS -->|treats| Breast_Cancer[Breast Cancer]
    PARP_INHIBITORS -->|used_to_treat| Hr_Deficient_Cancers[Hr-Deficient Cancers]
    PARP_INHIBITORS -->|contributes to| Transcription_Replication_Conf[Transcription-Replication Conflicts]
    Prmt_Inhibitors[Prmt Inhibitors] -->|modulates| PARP_INHIBITORS

Outgoing (19)

Target	Relation	Type	Str
Homologous Recombination-Deficient Cancers	treats	disease	0.95
Transcription-replication conflicts	underlies_sensitivity_to	process	0.90
Transcription-replication conflicts	underlie_sensitivity_to	process	0.90
Breast Cancer	treats	disease	0.90
PARP1	targets	protein	0.90
Homologous Recombination-Deficient Cancers	treats	disease	0.90
PARP	traps	protein	0.90
Homologous Recombination Deficiency	associated_with	phenotype	0.90
Hr-Deficient Cancers	used_to_treat	disease	0.90
HR Deficiency	associated_with	phenotype	0.88
Transcription-Replication Conflicts	contributes_to	process	0.88
HR-deficient Cancer	treats	disease	0.85
PARP1	inhibits	protein	0.85
Ovarian Cancer	treats	disease	0.85
Ovarian Cancer	treats	disease	0.85
Transcription-Replication Conflicts	causes	process	0.80
myelin preservation	protects_against	phenotype	0.50
cognitive outcomes in AD	modulates	phenotype	0.50
mitochondrial_dysfunction	inhibits	phenotype	0.50

Incoming (2)

Source	Relation	Type	Str
Prmt Inhibitors	modulates	drug	0.95
PRMT inhibitors	associated_with	drug	0.90

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitocho

neurodegeneration | 2026-04-15 | 0 hypotheses

Do oligodendrocytes require DNA repair enhancement or inhibition for neuroprotec

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

The debate revealed conflicting therapeutic approaches - enhancing DNA repair ve

closed · Rounds: 4 · Score: 1.00 · 2026-04-20

The abstract shows that damaged mitochondrial inner membranes appear early in PL

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

Related Research

Hypotheses and analyses mentioning PARP INHIBITORS in their description or question text

No additional research found